Quick facts!
Acne vulgaris is a chronic inflammatory dermatosis, notable for open or closed comedones and inflammatory lesions, including papules, pustules, or nodules. It is a clinical diagnosis.
Check out evidence-based management in the 2016 AAD guidelines.
Choosing Wisely recommends against routine microbiologic testing in the evaluation and management of acne.
Think about pathophysiology before you treat!
First, a few key terms:
- Pilosebaceous unit = hair follicle and attached sebaceous gland
- Infundibilum = part of follicle above the sebaceous gland
- Corneocyte = keratinized cells of stratum corneum (upper epidermis)
Pathophysiology:
- Follicular plugging
- Corneocytes become cohesive and increase keratin production
- Corneocytes accumulate and form plug in upper infundibulum
- Increased Sebum Production
- Stimulated by androgens
- Keratin and sebum accumulate to form a densely packed plug called a
comedone
- Acnes Proliferation
- Acnes live in the keratin/sebum comedone and proliferate
- Initiates immune response leading to pustule
- Inflammation
- With tight plug and influx of inflammatory cells, pressure builds
- Comedone wall ruptures under high pressure, leading to spill of bacteria/keratin, and marked inflammatory response
- Immune response creates cyst/nodule
Topical therapy
Benzoyl Peroxide:
- Antibacterial and mildly comedolytic
- Derm Rec: use 4% on face and 10% on body
Topical Antibiotics: Clindamycin 1%
- Should NEVER be used alone due to antimicrobial resistance
- Erythromycin has fallen out of favor due to resistance
Topical Retinoids: tretinoin, adapalene, tazarotene
- Binds to different retinoic acid receptors
- Comedolytic and anti-inflammatory
- Side effects: drying, peeling, redness (all dose dependent)
Combination therapies exist!
Note: Poor evidence for salicylic acid
Example Prescription for Topical Therapy
Morning:
- Benzoyl Peroxide: 4% on face, 10% on body
- Once patted dry, use clindamycin 1% lotion
Evening:
- Wash with face wash
- When dry, apply pea size amount of tretinoin (start 2 nights per week and
increase)
Systemic Antibiotics
Tetracycline class → doxycycline or minocycline
- Antibacterial and anti-inflammatory
- Goal to use for as short duration as possible. Re-evaluate in 3-4 months
- Always combine with topical therapy
- Dosing: doxycycline effective at 1.7-2.4 mg/kg
- Also can be used at subantimicrobial dosing at 40mg daily (or 20mg BID) in moderate inflammatory acne
Hormonal Agents
OCPs (women)
- Anti-androgenic → decreased production at level of ovary and increased sex hormone binding globulin (binding free testosterone)
- Usual contraindications apply
Spironolactone (women)
- Anti-androgenic → decreases testosterone production and competitively inhibits binding of testosterone to receptors in skin
- Improvement in acne seen at 50-200 mg
- Japanese trial: 200 mg for 8 weeks, followed by 50 mg taper every 4 weeks
- Only check potassium if on concomitant med
- Not FDA approved
Isotretinoin
- Indication: moderate/severe acne that is resistant to other treatments, produces physical scarring, or causes psychosocial distress
- Conventional Dosing: 0.5 mg/kg/day for first month. Increase to 1 mg/kg/day as tolerated.
- Low dose (0.25-0.4 mg/kg/day) reasonable for moderate acne
- Cumulative dose goal: 120-150 mg/kg
- Side effects: dose dependent, mimic hypervitaminosis A
- Lab monitoring: lipid panel and hepatic function panel (specifically looking at triglycerides, cholesterol, and transaminases)
- iPledge → Contraception (29% don’t comply)
Classification
Unfortunately there is no universal grading or classification system for acne, although definitions have been proposed.
Mild:
- Scattered, few comedonal or inflammatory lesions; <20 comedones or <15 inflammatory lesions or < 30 lesions total
Moderate:
- Greater number of sites or lesions than mild acne
- 20-100 comedones or 15-50 inflammatory lesions or 30–125 lesions total
Severe:
- Numerous large papules and/or pustules; multiple nodules and deep lesions; associated anxiety or depression secondary to acne; or scarring
Blog post based on Med-Peds Forum talk by Sam Masur, PGY3